# BioTissue Holdings Inc – FDA Inspection, Sep 1, 2026

Source: https://www.keypedia.com/records/fda_inspections/biotissue-holdings-inc/2f1713bf-8719-4236-8d5b-c9006f742ec8
Source feed: FDA_Inspections

> FDA inspection 1312222 of BioTissue Holdings Inc, September 01, 2026. Classification: Official Action Indicated (OAI). 6 citations under 21 CFR part 211. Form 483 issued. 10 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1312222
- Company Name: BioTissue Holdings Inc
- Inspection Date: 2026-09-01
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Florida District Office
- Citation Count: 6

## Related Documents

- [FDA Inspection 1304322 - 2026-02-18](https://www.keypedia.com/records/fda_inspections/biotissue-holdings-inc/521aafa6-8d2b-423e-89e1-46e5342a5736)
- [FDA Inspection 1230477 - 2024-03-06](https://www.keypedia.com/records/fda_inspections/biotissue-holdings-inc/bb637f4d-fcd0-472a-a159-54470476dd42)
- FDA Inspection 1101487 - 2019-08-15
- [FDA Inspection 1096403 - 2019-07-16](https://www.keypedia.com/records/fda_inspections/biotissue-holdings-inc/bf4d02a7-4b2b-49b5-a551-f9dac05d4348)
- [FDA Inspection 1040962 - 2018-02-06](https://www.keypedia.com/records/fda_inspections/biotissue-holdings-inc/adf9e664-a7c0-4ef7-a540-5973fcb81967)

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/ivan-e-reyes/69bac3eb-f63c-45f0-8420-85a7e06b884a)
- [Investigator](https://www.keypedia.com/people/nerming-v-briones/b2d9e685-a627-4f9e-854c-0588865fd1b6)

Company: https://www.keypedia.com/companies/biotissue-holdings-inc/2cac95ce-8ef8-451a-aa9d-4d03238d18d8

Office: https://www.keypedia.com/offices/florida-district-office/95b2a118-0b78-46e0-a54c-982bd7ce51c9